The CVs were 0.095, 0.106, and 0.109 for TARDP, HNRNPK, and WDR33, respectively, reflecting variability in gene expression across different categories of cancer that was no greater than the variability observed in different specimens of the same malignancy. This evidence concerns the gene WDR33 and cancer.